Transcription, Multi-bridging factor 1 Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | yes | yes: 6 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 16 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | yes | yes: 14 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 1 |
| GO:0005654 | nucleoplasm | 2 | 1 |
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0097014 | ciliary plasm | 5 | 1 |
| GO:0099568 | cytoplasmic region | 3 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: E9AGS1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 10 |
| GO:0003677 | DNA binding | 4 | 10 |
| GO:0005488 | binding | 1 | 10 |
| GO:0097159 | organic cyclic compound binding | 2 | 10 |
| GO:1901363 | heterocyclic compound binding | 2 | 10 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 34 | 38 | PF00656 | 0.554 |
| CLV_MEL_PAP_1 | 110 | 116 | PF00089 | 0.364 |
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.342 |
| CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.324 |
| CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.535 |
| CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.324 |
| CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.327 |
| CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.302 |
| DOC_MAPK_gen_1 | 134 | 143 | PF00069 | 0.307 |
| DOC_MAPK_gen_1 | 80 | 90 | PF00069 | 0.556 |
| DOC_MAPK_HePTP_8 | 131 | 143 | PF00069 | 0.407 |
| DOC_MAPK_MEF2A_6 | 134 | 143 | PF00069 | 0.407 |
| DOC_MAPK_MEF2A_6 | 82 | 90 | PF00069 | 0.550 |
| DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.524 |
| DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.580 |
| LIG_14-3-3_CanoR_1 | 109 | 117 | PF00244 | 0.454 |
| LIG_Actin_WH2_2 | 128 | 146 | PF00022 | 0.307 |
| LIG_deltaCOP1_diTrp_1 | 11 | 19 | PF00928 | 0.453 |
| LIG_FHA_1 | 76 | 82 | PF00498 | 0.473 |
| LIG_FHA_2 | 32 | 38 | PF00498 | 0.528 |
| LIG_FHA_2 | 6 | 12 | PF00498 | 0.565 |
| LIG_SUMO_SIM_anti_2 | 111 | 119 | PF11976 | 0.448 |
| LIG_TRAF2_1 | 125 | 128 | PF00917 | 0.448 |
| MOD_CDK_SPK_2 | 155 | 160 | PF00069 | 0.580 |
| MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.429 |
| MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.279 |
| MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.214 |
| MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.118 |
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.440 |
| MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.314 |
| MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.407 |
| MOD_NEK2_1 | 152 | 157 | PF00069 | 0.692 |
| MOD_NEK2_1 | 99 | 104 | PF00069 | 0.386 |
| MOD_PIKK_1 | 99 | 105 | PF00454 | 0.307 |
| MOD_PKA_1 | 31 | 37 | PF00069 | 0.542 |
| MOD_PKA_2 | 108 | 114 | PF00069 | 0.440 |
| MOD_Plk_1 | 75 | 81 | PF00069 | 0.514 |
| MOD_Plk_4 | 112 | 118 | PF00069 | 0.368 |
| MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.584 |
| MOD_SUMO_for_1 | 133 | 136 | PF00179 | 0.307 |
| TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.518 |
| TRG_NES_CRM1_1 | 104 | 119 | PF08389 | 0.364 |
| TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.253 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P3K7 | Leptomonas seymouri | 83% | 100% |
| A0A1X0P7A2 | Trypanosomatidae | 64% | 100% |
| A0A3S7WV69 | Leishmania donovani | 100% | 100% |
| A0A422NCU0 | Trypanosoma rangeli | 59% | 98% |
| A4H9X6 | Leishmania braziliensis | 93% | 100% |
| D0A0D7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
| E9ARX0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
| O14467 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 34% | 100% |
| O60869 | Homo sapiens | 36% | 100% |
| O94700 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 36% | 100% |
| P69736 | Rattus norvegicus | 36% | 100% |
| Q3T0V7 | Bos taurus | 36% | 100% |
| Q4QDK2 | Leishmania major | 97% | 100% |
| Q4WX89 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 27% | 100% |
| Q53IP3 | Gibberella fujikuroi | 27% | 100% |
| Q5A940 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 33% | 100% |
| Q6BXQ8 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 35% | 100% |
| Q6CIP4 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 37% | 100% |
| Q6FJN0 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 35% | 100% |
| Q6GPQ6 | Xenopus laevis | 35% | 100% |
| Q6PBY3 | Danio rerio | 32% | 100% |
| Q752P7 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 35% | 100% |
| Q871W6 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 26% | 100% |
| Q8TG23 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 33% | 100% |
| Q9JMG1 | Mus musculus | 36% | 100% |
| Q9LV58 | Arabidopsis thaliana | 38% | 100% |
| Q9LXT3 | Arabidopsis thaliana | 37% | 100% |
| Q9SJI8 | Arabidopsis thaliana | 37% | 100% |